Active Surveillance Provides Favorable Long-Term Outcomes for Small Pancreatic Neuroendocrine Tumors. Sakamoto Y, Takeda Y, Yamashita T, Onoyama T, et al. Pancreas 2026 Apr 1. doi: 10.1097/MPA.0000000000002642.

Read + Share

Amedeo Smart

Independent Medical Education

Sakamoto Y, Takeda Y, Yamashita T, Onoyama T, et al. Active Surveillance Provides Favorable Long-Term Outcomes for Small Pancreatic Neuroendocrine Tumors. Pancreas 2026 Apr 1. doi: 10.1097/MPA.0000000000002642.
PMID: 41920097